There were 1,706 press releases posted in the last 24 hours and 442,857 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Sandoz Canada launches Sandoz(R) Amphetamine XR for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image